Tenon Medical, Inc. (TNON)
Nasdaq · Healthcare · Medical Devices
$3.700.00%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $5.9M
- 52-week range
- $2.40 – $50.40
- 52-week change
- −90.96%
- EPS (trailing)
- −$44.86
- Next earnings
- Nov 12, 2026
Fiscal year to Dec 2025
- Revenue
- $3.9M (+20.35%)
- Net income
- −$12.6M
- Operating margin
- −324.3%
- Diluted EPS
- −$1.70
- Free cash flow
- −$11.0M
From the company’s annual report on SEC EDGAR.
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Headquarters: Los Gatos, United States · 26 employees · tenonmed.com